GU Cancers 2020 | RADVAX: pembrolizumab plus radiotherapy
Thanks for your feedback, this will help us improve our content for you!
Hans Hammers, MD, PhD, The University of Texas Southwestern, Dallas, TX, discusses the RADVAX trial (NCT02303990), a stratified Phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with advanced and metastatic Cancers. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.
Get great new content delivered to your inboxSign up